journal
MENU ▼
Read by QxMD icon Read
search

Clinical Advances in Hematology & Oncology: H&O

journal
https://www.readbyqxmd.com/read/28837127/highlights-in-ovarian-cancer-from-the-2017-american-society-of-clinical-oncology-annual-meeting-commentary
#1
Ursula A Matulonis
No abstract text is available yet for this article.
August 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28837126/highlights-in-ovarian-cancer-from-the-2017-american-society-of-clinical-oncology-annual-meeting
#2
(no author information available yet)
No abstract text is available yet for this article.
August 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28837125/highlights-in-aggressive-non-hodgkin-lymphoma-from-the-2017-american-society-of-clinical-oncology-annual-meeting-commentary
#3
Frederick L Locke
No abstract text is available yet for this article.
August 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28837124/highlights-in-aggressive-non-hodgkin-lymphoma-from-the-2017-american-society-of-clinical-oncology-annual-meeting
#4
(no author information available yet)
No abstract text is available yet for this article.
August 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28837123/highlights-from-the-xvii-international-workshop-on-chronic-lymphocytic-leukemia-commentary
#5
Susan M O'Brien
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28837122/highlights-from-the-xvii-international-workshop-on-chronic-lymphocytic-leukemia
#6
(no author information available yet)
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749919/philadelphia-chromosome-like-acute-lymphoblastic-leukemia-progress-in-a-new-cancer-subtype
#7
Julia Wells, Nitin Jain, Marina Konopleva
Philadelphia chromosome-like (Ph-like) acute lymphoblastic leukemia (ALL) is a newly described, high-risk subtype of B-cell ALL. It is characterized by a gene expression profile similar to that of Ph-positive ALL; however, the BCR-ABL1 fusion is not present. The World Health Organization classification of myeloid neoplasms and acute leukemia recently was updated to include the Ph-like or BCR-ABL1-like ALL subtype of B-cell ALL as a provisional entity. Unlike Ph-positive ALL, which is characterized by the pathognomonic BCR-ABL1 fusion, Ph-like ALL is characterized by a multitude of different genetic rearrangements and mutations...
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749918/immunotherapy-in-urothelial-cancer-part-2-adjuvant-neoadjuvant-and-adjunctive-treatment
#8
Steven S Yu, Leslie K Ballas, Eila C Skinner, Tanya B Dorff, Sarmad Sadeghi, David I Quinn
Urothelial cancer, which is predominantly seen in men, is common throughout the world. Most disease presents as non-muscle invasive bladder cancer (NMIBC), with cancer recurring or progressing to muscle invasive disease in more than 50% of patients after initial therapy. NMIBC is an immune responsive disease, as indicated by the use of intravesical bacillus Calmette-Guérin as treatment for more than 3 decades. The advent of T-cell checkpoint inhibitors, especially those directed at programmed death 1 (PD-1) and its ligand (PD-L1), has had a significant impact on the therapy of advanced urothelial cancer...
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749917/the-microbiome-a-basis-for-novel-immunomodulation-in-mice-and-men
#9
Hassane M Zarour
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749916/highlights-in-kidney-cancer-from-the-american-society-of-clinical-oncology-genitourinary-cancers-symposium
#10
(no author information available yet)
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749915/hem-onc-news
#11
Devon Schuyler
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749914/identifying-patients-with-leukemia-who-are-at-risk-for-fungal-infections
#12
Vijaya Raj Bhatt
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749913/new-insights-into-cytomegalovirus-infection-after-allogeneic-hematopoietic-stem-cell-transplant
#13
Michael Boeckh
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749912/which-patients-with-early-stage-triple-negative-breast-cancer-should-receive-a-platinum
#14
William M Sikov
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749911/letter-from-the-editor-asco-cage-match-br-vs-r-chop
#15
Brad S Kahl
No abstract text is available yet for this article.
July 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749910/no-treatment-for-cml-should-not-continue-indefinitely
#16
Gabriel Etienne, François-Xavier Mahon
No abstract text is available yet for this article.
June 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749909/yes-treatment-for-cml-should-continue-indefinitely
#17
Nicholas J Short, Elias Jabbour
No abstract text is available yet for this article.
June 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749908/combined-blockade-of-vascular-endothelial-growth-factor-and-programmed-death-1-pathways-in-advanced-kidney-cancer
#18
David J Einstein, David F McDermott
Targeted and immune-based therapies have improved outcomes in advanced kidney cancer, yet novel strategies are needed to extend the duration of these benefits and expand them to more patients. Combined inhibition of vascular endothelial growth factor (VEGF) and the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathways with therapeutic agents already in clinical use may offer such a strategy. Here, we describe the development and clinical evaluation of VEGF inhibitors and, separately, PD-1/PD-L1 inhibitors...
June 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749907/immunotherapy-in-urothelial-cancer-part-1-t-cell-checkpoint-inhibition-in-advanced-or-metastatic-disease
#19
Steven S Yu, Tanya B Dorff, Leslie K Ballas, Sarmad Sadeghi, Eila C Skinner, David I Quinn
Cancer of the urothelium is the sixth most common cancer in the United States and is seen predominantly in men. Most cases of this disease present as non-muscle-invasive bladder cancer (NMIBC), with cancer recurrence or progression to muscle-invasive cancer in more than 50% of patients after initial therapy. NMIBC is an immune-responsive disease, as indicated by the use of intravesical bacillus Calmette-Guérin as treatment for more than 3 decades. More recently, immunotherapy has seen much progress in a variety of cancers, including advanced and metastatic bladder cancer, in which historical 5-year survival rates are approximately 15%...
June 2017: Clinical Advances in Hematology & Oncology: H&O
https://www.readbyqxmd.com/read/28749906/locoregional-therapy-for-liver-metastases-in-colorectal-cancer
#20
Andrew S Kennedy
No abstract text is available yet for this article.
June 2017: Clinical Advances in Hematology & Oncology: H&O
journal
journal
40386
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"